Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q1

Core Insights - Tilray Brands, Inc. reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.03, and improved from a loss of $0.04 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company posted revenues of $209.5 million for the quarter ended August 2025, exceeding the Zacks Consensus Estimate by 1.29%, and showing an increase from year-ago revenues of $200.04 million [2] - Tilray Brands shares have increased approximately 29.3% since the beginning of the year, outperforming the S&P 500's gain of 14.8% [3] Earnings Outlook - The future performance of Tilray Brands' stock will largely depend on management's commentary during the earnings call and the company's earnings outlook, including current consensus earnings expectations for upcoming quarters [4] - The current consensus EPS estimate for the coming quarter is -$0.03 on revenues of $215.9 million, and -$0.11 on revenues of $877.28 million for the current fiscal year [7] Industry Context - The Medical - Products industry, to which Tilray Brands belongs, is currently ranked in the top 26% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]